Advances in Oral Drugs for Multiple Sclerosis
Today, Teva Pharmaceuticals had mixed reports to share regarding laquinimod, an experimental, oral drug for Multiple Sclerosis.
Click here to read more about the clinical study and other oral treatments for Multiple Sclerosis.
Press + Media
- Print Press Coverage
- TV Press Coverage
- Online Press Coverage
- Foundation Videos
- Foundation Blog
- Press Materials
Topics of Interest
Posted: Dec 09, 2014A team of researchers at the University of California, Riverside, along with other collaborators, have identified a ...
Posted: May 12, 2014Please join us for an opportunity to hear from our ...
Posted: Apr 07, 2014Please join us on May 2, 2014 at the Hyatt ...
Posted: Sep 24, 2013Taking place at the Hyatt Regency Century City on December ...